`
`
`
`Paper No. 4
`Filed: November 24, 2021
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`__________________
`SLAYBACK PHARMA LLC
`Petitioner,
`v.
`EYE THERAPIES, LLC
`
`Patent Owner.
`______________________
`
`Case No. IPR2022-00142
`U.S. Patent No. 8,293,742
`______________________
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
` PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), Patent Owner Eye Therapies, LLC (“Eye
`
`Case No. IPR2022-00142
`U.S. Patent No. 8,293,742
`
`
`
`
`Therapies”) hereby submits the following mandatory notices in connection with
`
`this proceeding.
`
`I.
`
`EYE THERAPIES’ POWER OF ATTORNEY
`
`A Power of Attorney appointing lead and back-up counsel is being filed
`
`concurrently with these notices.
`
`II. EYE THERAPIES’ MANDATORY NOTICES
`
`(a)
`
`The real party-in-interest for the Patent Owner is Eye Therapies, LLC. Other
`
`37 C.F.R. § 42.8(b)(1): Real Party-in-Interest
`
`real parties-in-interest include Bausch & Lomb, Inc. and Bausch & Lomb Ireland
`
`Limited.
`
`(b)
`
`37 C.F.R. § 42.8(b)(2): Related Matters
`
`1. Judicial
`
`The patent challenged here, U.S. Patent 8,293,742 (“the ’742 patent”), has
`
`been asserted in the following litigations:
`
`Case Caption
`Bausch & Lomb, Inc.; Bausch & Lomb Ireland
`Limited; and Eye Therapies, LLC v. Slayback Pharma
`LLC and Slayback Pharma India LLP
`Bausch & Lomb, Inc.; Bausch & Lomb Ireland
`Limited; and Eye Therapies, LLC v. Harrow Health,
`Inc.; Imprimisrx, LLC; Imprimisrx NJ, LLC; and
`Imprimis NJOF, LLC
`
`Case
`No.
`3:21-
`cv-
`16766
`3:21-
`cv-
`19252
`
`
`
`2
`
`D.N.J.
`
`Court Filed
`Sept.
`10,
`2021
`Oct.
`22,
`2021
`
`D.N.J.
`
`
`
`
`
`
`2. Administrative
`
`Case No. IPR2022-00142
`U.S. Patent No. 8,293,742
`
`Petitioner filed concurrently with this petition another petition for inter partes
`
`review, IPR2022-00146, of U.S. Patent No. 9,259,425.
`
`Case Caption
`
`Slayback Pharma LLC v. Eye Therapies, LLC
`
`IPR No.
`
`IPR2022-
`00146
`
`
`Patent
`
`9,259,425
`
`Filed
`Nov.
`4,
`2021
`
`
`
`37 C.F.R. § 42.8(b)(3) and (4): Lead and Back-Up Counsel and
`(c)
`Service Information
`
`Eye Therapies designates the following counsel to transact all business in the
`
`United States Patent & Trademark Office associated with the above-captioned
`
`proceeding.
`
`Lead Counsel
`Bryan C. Diner (Reg. No. 32,409)
`bryan.diner@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-4116
`Fax: (202) 408-4400
`
`
`Back-Up Counsel
`Justin J. Hasford (Reg. No. 62,180)
`justin.hasford@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-4175
`Fax: (202) 408-4400
`
`Jessica M. Lebeis (Reg. No. 73,931)
`jessica.lebeis@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`2 Seaport Lane
`Boston, MA 02210-2001
`
`
`
`3
`
`
`
`Case No. IPR2022-00142
`U.S. Patent No. 8,293,742
`
`(617) 646-1662
`Tel:
`Fax: (617) 646-1666
`
`Caitlin E. O’Connell (Reg. No. 73,934)
`caitlin.o’connell@finnegan.com
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, L.L.P.
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Tel:
`(202) 408-4004
`Fax: (202) 408-4400
`
`Please address all correspondence regarding this proceeding to lead and back-
`
`
`
`
`
`
`
`up counsel. Eye Therapies also consents to electronic service by email.
`
`Dated: November 24, 2021
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`By: /Bryan C. Diner/
`Bryan C. Diner, Lead Counsel
`Reg. No. 32,409
`Justin J. Hasford, Back-up Counsel
`Reg. No. 62,180
`Jessica M. Lebeis, Back-up Counsel
`Reg. No. 73,931
`Caitlin E. O’Connell, Back-up Counsel
`Reg. No. 73,934
`
`Finnegan, Henderson, Farabow, Garrett
` & Dunner, L.L.P.
`901 New York Ave. NW
`Washington, DC 20001-4413
`(202) 408-4000
`
`Counsel for Patent Owner
`
`4
`
`
`
`
`
`Case No. IPR2022-00142
`U.S. Patent No. 8,293,742
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Mandatory Notices Pursuant to 37 C.F.R. § 42.8 was served on
`
`November 24, 2021, via email directed to counsel of record for the Petitioner at the
`
`following:
`
`
`Louis H. Weinstein
`Reg. No. 45,205
`Windels Marx Lane & Mittendorf, LLP
`1 Giralda Farms
`Madison, NJ 07940
`lweinstein@windelsmarx.com
`
`Patrick G. Pollard
`Reg. No. 64,084
`Windels Marx Lane & Mittendorf, LLP
`1 Giralda Farms
`Madison, NJ 07940
`ppollard@windelsmarx.com
`
`
`
`
`Date: November 24, 2021
`
`
`
` /Jessica M. Lebeis/
`Jessica M. Lebeis, Back-Up Counsel
`Reg. No. 73,931
`
`Finnegan, Henderson, Farabow, Garrett &
`Dunner, LLP
`
`
`
`
`
`